Sutro Biopharma (STRO)'s 30-day implied volatility (IV30) was 98.6% at the close on November 6, 2026, down from 103.8% the day before, against a 52-week range of 62.0% to 155.7%. Its 20-day historical volatility was 107.6%.
Data as of November 6, 2026.